Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brinda Balakrishnan Insider Profile
4 Followers
Brinda Balakrishnan, Director at Aurinia Pharmaceuticals, holds 17.52K shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Brinda Balakrishnan Sold $520 shares of Aurinia Pharmaceuticals on May 22, 2024 for an estimated value of 2.98K.
Brinda Balakrishnan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Brinda Balakrishnan's holdings
Insider Roles
Director
Roles that Brinda Balakrishnan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Brinda Balakrishnan
Brinda Balakrishnan's Trading History
List of latest transactions for each holding click on a transaction to see Brinda Balakrishnan's performance on stock
You May Also Like
Brinda Balakrishnan insider profile FAQ
What is the percentage of profitable transactions made by Brinda Balakrishnan?
The percentage of profitable transactions made by Brinda Balakrishnan is ―.
What is the average return per transaction made by Brinda Balakrishnan?
The average return per transaction made by Brinda Balakrishnan is ―.
What stocks does Brinda Balakrishnan hold?
Brinda Balakrishnan holds: AUPH stocks.
What was Brinda Balakrishnan’s latest transaction?
Brinda Balakrishnan latest transaction was an Informative Sell of $2.98K.
What was Brinda Balakrishnan's most profitable transaction?
Brinda Balakrishnan’s most profitable transaction was an Informative Sell of AUPH stock on May 22, 2024. The return on the trade was -3.20%.
What is Brinda Balakrishnan's role in Aurinia Pharmaceuticals?
Brinda Balakrishnan's role in Aurinia Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.